Table 2.
Authors | Age (years)a; nb; country | Trimesters | UICc (μg/L) | Tgc (μg/L) | Findings | Comments | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pedersen et al. (38) | 21–38; n=20; Denmark | 3rd | 52d | 67 | Suggested high Tg might be due to an increase in iodine intake in pregnancy | Women did not take iodine supplements. | ||||||
Laurberg et al. (76) | NR; n=20; Denmark, Sweden, and Iceland | At term | Denmark | 39 | Denmark | 29.7 | Women living in Denmark had a significantly higher median Tg than those living in Sweden and Iceland (p<0.05) | No data on supplement use | ||||
Sweden | 78 | Sweden | 15.9 | |||||||||
Iceland | 118 | Iceland | 15.9 | |||||||||
Eltom et al. (78) | 20–40; n=48; Sweden and Sudan | 1st, 2nd, and 3rd | Trimesters | Trimesters | Sudanese women had a significantly higher median Tg than the Swedish women in the 1st (p<0.05), 2nd (p<0.001), and 3rd trimesters (p<0.01). | Women were followed throughout pregnancy; no data on supplement use | ||||||
1st | 2nd | 3rd | 1st | 2nd | 3rd | |||||||
Swedish | 89 | 89 | 76 | Swedish | 15.5 | 10.5 | 18.0 | |||||
Sudanese | 38 | 25 | 38 | Sudanese | 27.5 | 25.0 | 30.0 | |||||
Costeira et al. (79,93)e | 29.9; n=118; Portugal | 1st, 2nd and 3rd trimester, and 1 year PP | Trimester | Trimester | Tg in 1st and 2nd trimester increased from 11 to 13 μg/L in 3rd trimester | Women were followed throughout pregnancy; they did not take iodine supplements | ||||||
1st | 65 | 1st | 11.0 | |||||||||
2nd | 57 | 2nd | 11.0 | |||||||||
3rd | 70 | 3rd | 12.7 | |||||||||
1 year PP | 40 | 1 year PP | 9.7 | |||||||||
Brucker-Davis et al. (74) | 18–40; n=110; France | 1st | 116 | 17.4 | Tg was not correlated with UIC | Women did not take iodine supplements | ||||||
Raverot et al. (75) | 15.3–45.7; n=228; France | 1st, 2nd, and 3rd | Trimester | Trimester | Tg in the 1st, 2nd, or 3rd trimesters were not significantly different (p>0.05) | Women did not take iodine supplements | ||||||
1st | 69 | 1st | 16.6 | |||||||||
2nd | 91 | 2nd | 15.7 | |||||||||
3rd | 91 | 3rd | 16.2 | |||||||||
Andersen et al. (37) | 27.3; n=140; Denmark | At term | No supplements | NR | No supplements | 29.36 | Women taking supplements (i.e., 150 μg I/day) had a significantly lower Tg than those not taking supplements (p<0.001) | |||||
Supplements | NR | Supplements | 14.06 | |||||||||
All | 41f | All | 22.96 | |||||||||
Brough et al. (77) | 31; n=70; New Zealand | 3rd trimester or breastfeeding for >3 weeks | 3rd trimester | 85 | 3rd trimester | 15.9 | Tg was not correlated with UIC in women in the 3rd trimester and at PP | 70% pregnant women and 36% breastfeeding women used iodine supplements ranging from 100 to 150 μg I/day | ||||
PP | 74 | PP | 13.9 |
Range used unless mean reported.
Only subjects with no known thyroid disease or negative for TgAb were included.
Median used unless mean or geometric mean reported.
UIC reported as μg/g creatinine.
Tg was reported in Costeira et al. (79); UIC and the data on supplement use were reported in Costeira et al. (93). These two studies were counted as one study (79).
Geometric mean.
I, iodine; PP, postpartum.